0.9% sodium chloride water, also called as normal saline. It is a colorless, clear liquid. And it is sterile and no pyrogenic.
The global market for 0.9% Sodium Chloride Intravenous Infusion was estimated to be worth US$ 1241 million in 2023 and is forecast to a readjusted size of US$ 1557.7 million by 2030 with a CAGR of 3.3% during the forecast period 2024-2030
The sodium chloride injection bag market is primarily driven by its essential role in intravenous (IV) fluid therapy, making it a critical medical device in healthcare settings. These bags contain sterile saline solution, used for hydration, electrolyte balance, and dilution of medications, indispensable in various medical procedures, surgeries, and emergency care. The increasing prevalence of conditions requiring IV fluid administration, such as dehydration, infections, and trauma, fuels the demand for sodium chloride injection bags. However, the market also faces challenges, including the rising concerns about plastic waste and environmental impact associated with single-use medical devices like IV bags. Manufacturers are actively exploring sustainable packaging options and eco-friendly materials to address these environmental challenges. Additionally, supply chain disruptions and fluctuations in the availability and cost of raw materials can impact the production and distribution of sodium chloride injection bags, posing challenges for healthcare facilities in ensuring a stable supply for patient care.
Report Scope
This report aims to provide a comprehensive presentation of the global market for 0.9% Sodium Chloride Intravenous Infusion, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of 0.9% Sodium Chloride Intravenous Infusion by region & country, by Type, and by Application.
The 0.9% Sodium Chloride Intravenous Infusion market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 0.9% Sodium Chloride Intravenous Infusion.
麻豆原创 Segmentation
By Company
Kelun Group
Baxter
Fresenius Kabi
Shijiazhuang No.4 Pharmaceutical
CR Double-Crane
B.Braun
Otsuka
Cisen Pharmaceutical
Hospira (ICU Medical)
Huaren Pharmaceuticals
Zhejiang Chimin
Dubang Pharmaceutical
Guizhou Tiandi
Qidu Pharmaceutical
Segment by Type:
Flexible Bag
Plastic Bottles
Glass Bottle
Segment by Application
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of 0.9% Sodium Chloride Intravenous Infusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of 0.9% Sodium Chloride Intravenous Infusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of 0.9% Sodium Chloride Intravenous Infusion in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 0.9% Sodium Chloride Intravenous Infusion Product Introduction
1.2 Global 0.9% Sodium Chloride Intravenous Infusion 麻豆原创 Size Forecast
1.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales Value (2019-2030)
1.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales Volume (2019-2030)
1.2.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Price (2019-2030)
1.3 0.9% Sodium Chloride Intravenous Infusion 麻豆原创 Trends & Drivers
1.3.1 0.9% Sodium Chloride Intravenous Infusion Industry Trends
1.3.2 0.9% Sodium Chloride Intravenous Infusion 麻豆原创 Drivers & Opportunity
1.3.3 0.9% Sodium Chloride Intravenous Infusion 麻豆原创 Challenges
1.3.4 0.9% Sodium Chloride Intravenous Infusion 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global 0.9% Sodium Chloride Intravenous Infusion Players Revenue Ranking (2023)
2.2 Global 0.9% Sodium Chloride Intravenous Infusion Revenue by Company (2019-2024)
2.3 Global 0.9% Sodium Chloride Intravenous Infusion Players Sales Volume Ranking (2023)
2.4 Global 0.9% Sodium Chloride Intravenous Infusion Sales Volume by Company Players (2019-2024)
2.5 Global 0.9% Sodium Chloride Intravenous Infusion Average Price by Company (2019-2024)
2.6 Key Manufacturers 0.9% Sodium Chloride Intravenous Infusion Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers 0.9% Sodium Chloride Intravenous Infusion Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of 0.9% Sodium Chloride Intravenous Infusion
2.9 0.9% Sodium Chloride Intravenous Infusion 麻豆原创 Competitive Analysis
2.9.1 0.9% Sodium Chloride Intravenous Infusion 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by 0.9% Sodium Chloride Intravenous Infusion Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 0.9% Sodium Chloride Intravenous Infusion as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Flexible Bag
3.1.2 Plastic Bottles
3.1.3 Glass Bottle
3.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales Value by Type
3.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales Value, by Type (2019-2030)
3.2.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Value, by Type (%) (2019-2030)
3.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Volume by Type
3.3.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales Volume, by Type (2019-2030)
3.3.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Volume, by Type (%) (2019-2030)
3.4 Global 0.9% Sodium Chloride Intravenous Infusion Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Other
4.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales Value by Application
4.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales Value, by Application (2019-2030)
4.2.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Value, by Application (%) (2019-2030)
4.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Volume by Application
4.3.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales Volume, by Application (2019-2030)
4.3.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Volume, by Application (%) (2019-2030)
4.4 Global 0.9% Sodium Chloride Intravenous Infusion Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales Value by Region
5.1.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales Value by Region (2019-2024)
5.1.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Value by Region (2025-2030)
5.1.4 Global 0.9% Sodium Chloride Intravenous Infusion Sales Value by Region (%), (2019-2030)
5.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales Volume by Region
5.2.1 Global 0.9% Sodium Chloride Intravenous Infusion Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global 0.9% Sodium Chloride Intravenous Infusion Sales Volume by Region (2019-2024)
5.2.3 Global 0.9% Sodium Chloride Intravenous Infusion Sales Volume by Region (2025-2030)
5.2.4 Global 0.9% Sodium Chloride Intravenous Infusion Sales Volume by Region (%), (2019-2030)
5.3 Global 0.9% Sodium Chloride Intravenous Infusion Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America 0.9% Sodium Chloride Intravenous Infusion Sales Value, 2019-2030
5.4.2 North America 0.9% Sodium Chloride Intravenous Infusion Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe 0.9% Sodium Chloride Intravenous Infusion Sales Value, 2019-2030
5.5.2 Europe 0.9% Sodium Chloride Intravenous Infusion Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Sales Value, 2019-2030
5.6.2 Asia Pacific 0.9% Sodium Chloride Intravenous Infusion Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America 0.9% Sodium Chloride Intravenous Infusion Sales Value, 2019-2030
5.7.2 South America 0.9% Sodium Chloride Intravenous Infusion Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa 0.9% Sodium Chloride Intravenous Infusion Sales Value, 2019-2030
5.8.2 Middle East & Africa 0.9% Sodium Chloride Intravenous Infusion Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions 0.9% Sodium Chloride Intravenous Infusion Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions 0.9% Sodium Chloride Intravenous Infusion Sales Value
6.2.1 Key Countries/Regions 0.9% Sodium Chloride Intravenous Infusion Sales Value, 2019-2030
6.2.2 Key Countries/Regions 0.9% Sodium Chloride Intravenous Infusion Sales Volume, 2019-2030
6.3 United States
6.3.1 United States 0.9% Sodium Chloride Intravenous Infusion Sales Value, 2019-2030
6.3.2 United States 0.9% Sodium Chloride Intravenous Infusion Sales Value by Type (%), 2023 VS 2030
6.3.3 United States 0.9% Sodium Chloride Intravenous Infusion Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe 0.9% Sodium Chloride Intravenous Infusion Sales Value, 2019-2030
6.4.2 Europe 0.9% Sodium Chloride Intravenous Infusion Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe 0.9% Sodium Chloride Intravenous Infusion Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China 0.9% Sodium Chloride Intravenous Infusion Sales Value, 2019-2030
6.5.2 China 0.9% Sodium Chloride Intravenous Infusion Sales Value by Type (%), 2023 VS 2030
6.5.3 China 0.9% Sodium Chloride Intravenous Infusion Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan 0.9% Sodium Chloride Intravenous Infusion Sales Value, 2019-2030
6.6.2 Japan 0.9% Sodium Chloride Intravenous Infusion Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan 0.9% Sodium Chloride Intravenous Infusion Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea 0.9% Sodium Chloride Intravenous Infusion Sales Value, 2019-2030
6.7.2 South Korea 0.9% Sodium Chloride Intravenous Infusion Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea 0.9% Sodium Chloride Intravenous Infusion Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia 0.9% Sodium Chloride Intravenous Infusion Sales Value, 2019-2030
6.8.2 Southeast Asia 0.9% Sodium Chloride Intravenous Infusion Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia 0.9% Sodium Chloride Intravenous Infusion Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India 0.9% Sodium Chloride Intravenous Infusion Sales Value, 2019-2030
6.9.2 India 0.9% Sodium Chloride Intravenous Infusion Sales Value by Type (%), 2023 VS 2030
6.9.3 India 0.9% Sodium Chloride Intravenous Infusion Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Kelun Group
7.1.1 Kelun Group Company Information
7.1.2 Kelun Group Introduction and Business Overview
7.1.3 Kelun Group 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Kelun Group 0.9% Sodium Chloride Intravenous Infusion Product Offerings
7.1.5 Kelun Group Recent Development
7.2 Baxter
7.2.1 Baxter Company Information
7.2.2 Baxter Introduction and Business Overview
7.2.3 Baxter 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Baxter 0.9% Sodium Chloride Intravenous Infusion Product Offerings
7.2.5 Baxter Recent Development
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Company Information
7.3.2 Fresenius Kabi Introduction and Business Overview
7.3.3 Fresenius Kabi 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Fresenius Kabi 0.9% Sodium Chloride Intravenous Infusion Product Offerings
7.3.5 Fresenius Kabi Recent Development
7.4 Shijiazhuang No.4 Pharmaceutical
7.4.1 Shijiazhuang No.4 Pharmaceutical Company Information
7.4.2 Shijiazhuang No.4 Pharmaceutical Introduction and Business Overview
7.4.3 Shijiazhuang No.4 Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Shijiazhuang No.4 Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Offerings
7.4.5 Shijiazhuang No.4 Pharmaceutical Recent Development
7.5 CR Double-Crane
7.5.1 CR Double-Crane Company Information
7.5.2 CR Double-Crane Introduction and Business Overview
7.5.3 CR Double-Crane 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CR Double-Crane 0.9% Sodium Chloride Intravenous Infusion Product Offerings
7.5.5 CR Double-Crane Recent Development
7.6 B.Braun
7.6.1 B.Braun Company Information
7.6.2 B.Braun Introduction and Business Overview
7.6.3 B.Braun 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2019-2024)
7.6.4 B.Braun 0.9% Sodium Chloride Intravenous Infusion Product Offerings
7.6.5 B.Braun Recent Development
7.7 Otsuka
7.7.1 Otsuka Company Information
7.7.2 Otsuka Introduction and Business Overview
7.7.3 Otsuka 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Otsuka 0.9% Sodium Chloride Intravenous Infusion Product Offerings
7.7.5 Otsuka Recent Development
7.8 Cisen Pharmaceutical
7.8.1 Cisen Pharmaceutical Company Information
7.8.2 Cisen Pharmaceutical Introduction and Business Overview
7.8.3 Cisen Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Cisen Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Offerings
7.8.5 Cisen Pharmaceutical Recent Development
7.9 Hospira (ICU Medical)
7.9.1 Hospira (ICU Medical) Company Information
7.9.2 Hospira (ICU Medical) Introduction and Business Overview
7.9.3 Hospira (ICU Medical) 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Hospira (ICU Medical) 0.9% Sodium Chloride Intravenous Infusion Product Offerings
7.9.5 Hospira (ICU Medical) Recent Development
7.10 Huaren Pharmaceuticals
7.10.1 Huaren Pharmaceuticals Company Information
7.10.2 Huaren Pharmaceuticals Introduction and Business Overview
7.10.3 Huaren Pharmaceuticals 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Huaren Pharmaceuticals 0.9% Sodium Chloride Intravenous Infusion Product Offerings
7.10.5 Huaren Pharmaceuticals Recent Development
7.11 Zhejiang Chimin
7.11.1 Zhejiang Chimin Company Information
7.11.2 Zhejiang Chimin Introduction and Business Overview
7.11.3 Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Zhejiang Chimin 0.9% Sodium Chloride Intravenous Infusion Product Offerings
7.11.5 Zhejiang Chimin Recent Development
7.12 Dubang Pharmaceutical
7.12.1 Dubang Pharmaceutical Company Information
7.12.2 Dubang Pharmaceutical Introduction and Business Overview
7.12.3 Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Dubang Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Offerings
7.12.5 Dubang Pharmaceutical Recent Development
7.13 Guizhou Tiandi
7.13.1 Guizhou Tiandi Company Information
7.13.2 Guizhou Tiandi Introduction and Business Overview
7.13.3 Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Guizhou Tiandi 0.9% Sodium Chloride Intravenous Infusion Product Offerings
7.13.5 Guizhou Tiandi Recent Development
7.14 Qidu Pharmaceutical
7.14.1 Qidu Pharmaceutical Company Information
7.14.2 Qidu Pharmaceutical Introduction and Business Overview
7.14.3 Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Qidu Pharmaceutical 0.9% Sodium Chloride Intravenous Infusion Product Offerings
7.14.5 Qidu Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 0.9% Sodium Chloride Intravenous Infusion Industrial Chain
8.2 0.9% Sodium Chloride Intravenous Infusion Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 0.9% Sodium Chloride Intravenous Infusion Sales Model
8.5.2 Sales Channel
8.5.3 0.9% Sodium Chloride Intravenous Infusion Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Kelun Group
Baxter
Fresenius Kabi
Shijiazhuang No.4 Pharmaceutical
CR Double-Crane
B.Braun
Otsuka
Cisen Pharmaceutical
Hospira (ICU Medical)
Huaren Pharmaceuticals
Zhejiang Chimin
Dubang Pharmaceutical
Guizhou Tiandi
Qidu Pharmaceutical
听
听
*If Applicable.